These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4263716)

  • 1. Leukofibrinolysis.
    Lewis JH; Szeto IL; Bayer WL; Curiel DC
    Blood; 1972 Dec; 40(6):844-55. PubMed ID: 4263716
    [No Abstract]   [Full Text] [Related]  

  • 2. [THE SOLUBILITY OF FIBRIN DEPOSITS].
    HEY D; BENEKE G
    Verh Dtsch Ges Pathol; 1963; 47():232-4. PubMed ID: 14168358
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoephelometric determination of fibrinogen and its derivatives in plasma.
    Farrell GW; Wolf P
    J Immunol Methods; 1972 May; 1(3):217-29. PubMed ID: 4116307
    [No Abstract]   [Full Text] [Related]  

  • 4. Radioimmunoassay of fibrinogen and its proteolysis products.
    Catt KJ; Hirsh J; Castelan DJ; Niall HD; Tregear GW
    Thromb Diath Haemorrh; 1968 Nov; 20(1):1-6. PubMed ID: 4236937
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of soluble fibrin monomer complexes in blood by means of protamine sulphate test.
    Lipiński B; Worowski K
    Thromb Diath Haemorrh; 1968 Nov; 20(1):44-9. PubMed ID: 4236938
    [No Abstract]   [Full Text] [Related]  

  • 6. FIBRINOGEN BREAKDOWN PRODUCTS.
    LEWIS JH; WILSON JH
    Am J Physiol; 1964 Nov; 207():1053-7. PubMed ID: 14237449
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of inhibitors of plasmin and plasminogen activation on the streptokinase-induced fibrinolytic state.
    Spöttl F; Holzknecht F
    Thromb Diath Haemorrh; 1970 Oct; 24(1):101-12. PubMed ID: 4249466
    [No Abstract]   [Full Text] [Related]  

  • 8. The dissolution of human cross-linked plasma fibrin clots by the equimolar human plasmin-derived light (B) chain-streptokinase complex. The acceleration of clot lysis by pretreatment of fibrin clots with the light (B) chain.
    Summaria L; Boreisha IG; Arzadon L; Robbins KC
    Thromb Res; 1977 Sep; 11(3):377-89. PubMed ID: 144332
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinolysis of soluble and polymerized des-AA/des-AABB fibrin compared to fibrinogenolysis in buffer and in fibrinogen-boosted serum. Evidence that plasminogen activators are responsible for preferential degradation of polymerized fibrin.
    Brosstad F
    Thromb Res; 1979; 15(3-4):497-504. PubMed ID: 158847
    [No Abstract]   [Full Text] [Related]  

  • 10. The chemotactic activity of fibrin lysis products.
    Stecher VJ; Sorkin E
    Int Arch Allergy Appl Immunol; 1972; 43(6):879-86. PubMed ID: 4267205
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on thrombolysis with streptokinase. IV. Immunofluorescent investigations on the fibrin pattern and the content of plasminogen and of plasma-plasmin-inhibitors in clots and thrombi of various age.
    Gottlob R; el-Nashef B; Donas P; Piza F; Kolb R
    Thromb Diath Haemorrh; 1973 May; 29(2):393-407. PubMed ID: 4586907
    [No Abstract]   [Full Text] [Related]  

  • 12. [Leukofibrinolysis enhanced by leukocyte adhesion to a clot with antifibrin antibodies].
    Tsybikov NN; Kradenov AV
    Patol Fiziol Eksp Ter; 1991; (4):12-3. PubMed ID: 1798638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [THE CURRENT STATUS OF FIBRINOLYTIC THERAPY].
    KAPPERT A
    Med Klin; 1963 Nov; 58():1844-6. PubMed ID: 14100260
    [No Abstract]   [Full Text] [Related]  

  • 14. [In vitro studies and model calculations on the kinetics of fibrinolysis with streptokinase].
    Senf L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):899-907. PubMed ID: 94884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of streptokinase on the fibrin binding site of plasmin(ogen).
    Cederholm-Williams SA
    Thromb Res; 1981 Mar; 21(6):649-54. PubMed ID: 6455776
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the fibrin stabilizing factor in human platelets: its content in normal thrombocytes and in platelets with functional defects.
    Wenzel E; Oppolzer R
    Acta Univ Carol Med Monogr; 1972; 53():173-8. PubMed ID: 4133928
    [No Abstract]   [Full Text] [Related]  

  • 17. Clearance of coagulation and fibrinolysis products by the reticuloendothelial system.
    Walsh RT; Barnhart MI
    Thromb Diath Haemorrh Suppl; 1969; 36():83-97. PubMed ID: 4912574
    [No Abstract]   [Full Text] [Related]  

  • 18. FATE OF STREPTOCOCCAL M PROTEIN AFTER EXPOSURE TO PLASMIN AND HUMAN LEUKOCYTES.
    KANTOR FS
    Yale J Biol Med; 1964 Feb; 36(4):259-67. PubMed ID: 14119861
    [No Abstract]   [Full Text] [Related]  

  • 19. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS.
    BACK N; HIRAMOTO R; AMBRUS JL
    Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764
    [No Abstract]   [Full Text] [Related]  

  • 20. THE PATHOGENIC ROLE OF THE COAGULATION PROCESS IN RABBIT MASUGI NEPHRITIS.
    VASSALLI P; MCCLUSKEY RT
    Am J Pathol; 1964 Oct; 45(4):653-77. PubMed ID: 14217678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.